Equities

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)25.08
  • Today's Change0.39 / 1.58%
  • Shares traded8.97m
  • 1 Year change-19.51%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments20,55722,97921,013
Total Receivables, Net21,52620,65219,175
Total Inventory11,50710,67210,438
Prepaid expenses867916794
Other current assets, total1,5271,8461,390
Total current assets55,98457,06452,811
Property, plant & equipment, net7,5166,5705,836
Goodwill, net829829829
Intangibles, net3,1962,8262,593
Long term investments9,6226,1043,105
Note receivable - long term------
Other long term assets----17
Total assets78,58774,66566,118
LIABILITIES
Accounts payable11,84211,20011,287
Accrued expenses2,7782,6601,361
Notes payable/short-term debt11,66512,92911,905
Current portion long-term debt/capital leases250707246
Other current liabilities, total9,7009,8997,454
Total current liabilities36,23537,39532,254
Total long term debt3,9022,1851,251
Total debt15,81715,82113,402
Deferred income tax640395332
Minority interest1,7591,5732,264
Other liabilities, total1,1321,053955
Total liabilities43,66842,60037,056
SHAREHOLDERS EQUITY
Common stock1,6261,6261,626
Additional paid-in capital10,10610,1069,957
Retained earnings (accumulated deficit)23,21220,34717,497
Treasury stock - common------
Unrealized gain (loss)(30)(16)--
Other equity, total6.032.75(17)
Total equity34,91932,06529,062
Total liabilities & shareholders' equity78,58774,66566,118
Total common shares outstanding1,6261,6261,626
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.